Home > Formulary : Paediatric > Recent Decisions > 2023 >
Decisions 21st March 2023
New Drug Requests
Approved
Ivermectin (oral) (TLS Red)
-
For treatment resistant scabies, specialist use only, not for children under 15kg.
Hydrocortisone sodium phosphate 3.35mg/mL eye drops (Softacort) (TLS Red)
-
For short-term treatment of mild non-infectious allergic or inflammatory conjunctival diseases for patients who are at increased risk of raised intraocular pressure and who require a preservative-free option.
Fluorescein IV (TLS Red)
-
For imaging of retinal vasculature for diagnosis of retinopathy of prematurity.
Shared Care Protocols
Nil
Traffic Light Status Change Requests
-
Insuman Comb 25 to be changed from TLS Green to TLS Blue for existing patients only
Other Formulary Decisions
-
Paediatric emollient chapter page to be updated to mirror changes to the adult chapter.
-
Changes to Amber Traffic Light categories and definitions were agreed:
- Amber 3 month and 1 month - no change
- Amber No SCP renamed as Amber Specialist Recommended
- New category - Amber Specialist Initiated.
-
Changes to the New Drug Request Application paperwork were agreed including removal of short forms. A single New Drug Request form to be used going forward.
-
Insuman insulins are being discontinued. These will be removed from the Joint Formulary when supplies are exhausted.
-
Desflurane to be removed from the formulary as this is no longer used.
-
Further work is required to explore use of CareSens test strips.
-
Isotretinoin to be changed from TLS Red 'hospital consultant only' to TLS Red 'restricted to dermatology specialist teams only'.